Rani Therapeutics Holdings, Inc. (RANI)
0.8527
+0.01
(+1.51%)
USD |
NASDAQ |
Aug 31, 12:18
Rani Therapeutics Holdings 1 Year Total Returns (Daily) : 55.61% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 55.61% |
| August 27, 2026 | 51.62% |
| August 26, 2026 | 41.89% |
| August 25, 2026 | 48.11% |
| August 24, 2026 | 40.78% |
| August 21, 2026 | 60.41% |
| August 20, 2026 | 60.72% |
| August 19, 2026 | 66.93% |
| August 18, 2026 | 49.04% |
| August 17, 2026 | 44.71% |
| August 14, 2026 | 42.98% |
| August 13, 2026 | 51.12% |
| August 12, 2026 | 51.19% |
| August 11, 2026 | 57.00% |
| August 10, 2026 | 47.14% |
| August 07, 2026 | 48.59% |
| August 06, 2026 | 42.10% |
| August 05, 2026 | 42.86% |
| August 04, 2026 | 49.64% |
| August 03, 2026 | 51.65% |
| July 31, 2026 | 44.45% |
| July 30, 2026 | 49.94% |
| July 29, 2026 | 56.31% |
| July 28, 2026 | 48.72% |
| July 27, 2026 | 52.27% |
| Date | Value |
|---|---|
| July 24, 2026 | 69.70% |
| July 23, 2026 | 95.60% |
| July 22, 2026 | 105.0% |
| July 21, 2026 | 64.52% |
| July 20, 2026 | 65.13% |
| July 17, 2026 | 67.26% |
| July 16, 2026 | 63.39% |
| July 15, 2026 | 58.70% |
| July 14, 2026 | -7.07% |
| July 13, 2026 | -1.77% |
| July 10, 2026 | 4.07% |
| July 09, 2026 | 5.64% |
| July 08, 2026 | 15.23% |
| July 07, 2026 | 32.26% |
| July 06, 2026 | 48.11% |
| July 02, 2026 | 45.04% |
| July 01, 2026 | 49.64% |
| June 30, 2026 | 47.97% |
| June 29, 2026 | 38.53% |
| June 26, 2026 | 42.34% |
| June 25, 2026 | 46.70% |
| June 24, 2026 | 54.39% |
| June 23, 2026 | 54.08% |
| June 22, 2026 | 54.39% |
| June 18, 2026 | 54.02% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cocrystal Pharma, Inc. | -29.94% |
| CNBX Pharmaceuticals, Inc. | -72.00% |
| GB Sciences, Inc. | 0.00% |
| Arvinas, Inc. | 18.30% |
| Fulcrum Therapeutics, Inc. | -42.11% |